What's breaking now, across thousands of outlets.
Two studies involving investigators at Cedars-Sinai Guerin Children's and the University of Cambridge, U.K., highlight the growing potential of whole-genome sequencing to transform the diagnosis and treatment of childhood conditions such as cerebral palsy and cancer.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
Chewy's recurring revenue model and high margins clash with Five Below's explosive growth and valuation appeal, here's which edge matters more for your 2027 portfolio.
Five medical organisations have united in an appeal to the NSW premier to pause the planned expansion of pharmacist prescribing powers on safety grounds.
The payments by Merck, Eli Lilly, Novartis and AstraZeneca allegedly helped fund a corruption scheme that kept drug prices high and limited competition across Russia’s public healthcare system.
The US Food and Drug Administration on Monday approved a low-cost version of a twice-yearly HIV prevention shot, bringing the breakthrough drug closer to market in low-income countries.
uniQure has aligned with the FDA on what the company calls key elements of the confirmatory study design: The study is being designed as a randomized, standard-of-care trial enrolling approximately…
(MedPage Today) -- We heard about the outbreak by accident. In December 2025, I (Meyer) was chatting with a friend who has a teenager in a rival San Francisco high school.
